Compounds > sulfinosine
Page last updated: 2024-09-03

sulfinosine and Lung Neoplasms

sulfinosine has been researched along with Lung Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanazir, S; Konjević, G; Medić-Mijacević, L; Milosević, J; Pejanović, V; Rakić, L; Ruzdijić, S; Stokić, Z1
Andjelkovic, T; Bankovic, J; Markovic, ID; Pesic, M; Ruzdijic, S; Tanic, N1
Andjelković, T; Banković, J; Marković, ID; Pesić, M; Rakić, L; Ruzdijić, S1

Other Studies

3 other study(ies) available for sulfinosine and Lung Neoplasms

ArticleYear
Sulfinosine-induced cell growth inhibition and apoptosis in human lung carcinomas in vitro.
    Investigational new drugs, 2002, Volume: 20, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Survival; DNA, Neoplasm; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Purine Nucleosides; Tetrazolium Salts; Thiazoles; Trypan Blue; Tumor Cells, Cultured

2002
Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R).
    Cancer biology & therapy, 2008, Volume: 7, Issue:7

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Curcumin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Exons; Genes, p53; Humans; Lung Neoplasms; Mutation; Phenotype; Purine Nucleosides

2008
Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R).
    Investigational new drugs, 2009, Volume: 27, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cysteine; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Glutathione; Humans; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Purine Nucleosides

2009